Remedy Meds prices its compounded GLP-1 program the way most telehealth services do, with a subscription that hides its full range behind an intake quiz. This independent review explains the pricing model, where it sits in the market, and the genetic context worth understanding before you sign up.

LillyDirect prices its GLP-1 program as a manufacturer direct-to-patient model. This independent PlexusDx review explains what drives the monthly number, the cash-pay versus insurance reality, brand versus compounded routes, transparent PlexusDx pricing, and the genetic context no price tag covers.

This review of Found, a telehealth GLP-1 weight-loss program built on compounded medication with providers and coaching included, compares compounding standards, clinical pathways, and how PlexusDx's precision-genetics approach differs from traditional GLP-1 access models.

9Amhealth reviews often focus on convenience and cost. This article explains how to assess any telemedicine GLP-1 provider's credentialing, pharmacy licensing, prescriber oversight, and whether compounded or branded medications align with your clinical needs and genetic predispositions.

Calibrate GLP-1 programs offer structured treatment protocols combining medications with lifestyle support.

Strut Health offers compounded GLP-1 medications through licensed pharmacies. This review evaluates compounding standards, licensure requirements, and how genetic insights can inform more personalized treatment selection beyond generic protocols.

A breakdown of how Direct Meds prices its GLP-1 program, including the subscription structure and what drives the monthly total. It explains the cash-pay and branded-versus-compounded split, references the April 2026 telehealth market range, and describes the one cost input no quote includes: your baseline genetics.

An iV.im Review reveals key criteria for evaluating GLP-1 telehealth providers: pharmacy licensing, prescriber qualifications, and whether treatment aligns with your individual health profile. Understanding these factors helps patients make informed decisions.

FuturHealth Cost represents one market approach to GLP-1 subscription pricing.

An independent, structured editorial review of AgelessRx across the whole buying decision: the program at a glance, how provider access and visits work, medication sourcing and the pharmacy pathway, what you will actually spend, the evidence base, and the genetic context most telehealth programs skip.

Form Health is a direct-to-consumer GLP-1 telehealth platform offering semaglutide and tirzepatide with provider oversight.

An independent editorial review of Agile Health that starts from the criteria that actually matter for trust: state-licensed clinicians, the 503A compounding pathway, real clinical oversight, and pricing transparency. It also covers the pathway-level genetic context that no telehealth review score can capture before you commit.

Felix Health operates a telehealth model for GLP-1 prescriptions with flat monthly pricing. This review evaluates their business structure, clinical oversight, and how their approach compares to compounded GLP-1 options available through licensed 503A pharmacies.

Felix Health operates as a licensed telehealth platform connecting patients with providers for GLP-1 medications. Legitimacy depends on verifying state licensure, pharmacy partnerships, and clinical protocols.

TRT Nation Review is a testosterone replacement therapy platform that has expanded into GLP-1 compounded peptide offerings.

Shed Price provides telehealth GLP-1 prescriptions with transparent pricing models. Understanding how Shed Price compares to compounded options—and how individual genetic factors influence medication efficacy—can help patients make cost-effective, personalized treatment decisions.

Shed GLP-1 is a telehealth platform offering GLP-1 medications alongside lifestyle support. Clinical evidence supports GLP-1 efficacy for weight management and metabolic health, while genetic factors and biomarkers may help providers tailor treatment selection and dosing for individual patients.

Shed Cost is a telehealth platform focused on transparent GLP-1 medication pricing and accessibility. Understanding your genetic predispositions in peptide pathways can help inform treatment selection and cost considerations with your provider.

Ro is a direct-to-consumer telehealth platform offering GLP-1 medications for weight management and diabetes. This review examines Ro's clinical approach, pricing structure, and how genetic insights into peptide pathways may inform more personalized GLP-1 decisions across telehealth providers.

PlushCare is a telemedicine platform offering remote GLP-1 prescriptions through licensed physicians. This review examines PlushCare's model, costs, and clinical workflows compared to precision-based compounding approaches that incorporate genetic and metabolic context.

Orderly Meds Reviews is a comparison platform for compounded GLP-1 providers. This guide explains how to assess pharmacy quality, verify licensing, and understand the clinical differences between reputable compounding services and cost-cutting alternatives.

Orderly Meds Review is a medication management platform that helps clinicians and patients match GLP-1 therapies to individual metabolic profiles. Understanding genetic predispositions alongside clinical data can support more targeted, personalized treatment conversations.

Noom and Weightwatchers offer distinct behavioral frameworks for weight management—psychology-first vs. point-based systems—but neither replaces medical evaluation or medication therapy.

Mochi is a telehealth platform offering GLP-1 medications through remote consultations. This review evaluates Mochi's clinical approach, cost structure, and how precision-based alternatives like compounded GLP-1 with genetic assessment may support more individualized treatment planning.

LillyDirect Tirzepatide is Eli Lilly's direct-to-patient platform for brand-name tirzepatide (Mounjaro). This article explains how LillyDirect works, eligibility criteria, pricing, and how it compares to compounded tirzepatide alternatives available through licensed pharmacies.

LifeMD is a telehealth platform offering remote GLP-1 prescriptions through licensed providers. This review examines LifeMD's model, clinical approach, pricing, and how precision compounding services like PlexusDx differ in sourcing, customization, and genetic assessment capabilities.

LifeMD is a telehealth platform offering remote GLP-1 prescription services for weight loss and diabetes management. This review examines LifeMD's model, costs, clinical oversight, and how it compares to compounded GLP-1 providers like PlexusDx.

Henry Meds is a telehealth platform offering GLP-1 prescriptions through licensed providers. This review explores their clinical model, credentialing practices, and how their approach compares to direct compounding pharmacies and alternatives for personalized weight management.

Hers is a telehealth platform offering prescription GLP-1 medications for weight management through remote consultations. This review examines Hers' clinical model, costs, eligibility criteria, and how precision-based approaches like genetic assessment may complement telehealth evaluation.

Henry Meds is a telehealth platform offering GLP-1 medications through licensed pharmacies.